Clinical Trial Update: Impact of Tight Glycaemic Control in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tight glycemic control in patients with acute myocardial infarction and hyperglycemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Melbourne Health | Conditions: Myocardial Infarct, Hyperglycemia | Phase 4 | Status: TERMINATED